First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial.
Lancet
; 389(10083): 2031-2040, 2017 May 20.
Article
in En
| MEDLINE
| ID: mdl-28342637
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prednisolone
/
Antineoplastic Combined Chemotherapy Protocols
/
Pemphigus
/
Rituximab
Type of study:
Clinical_trials
/
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Lancet
Year:
2017
Type:
Article